Trial Profile
The antihypertensive efficacy of Azilsartan on Nocturnalblood pressure by automated sphygmomanometer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2013
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary) ; Olmesartan medoxomil
- Indications Hypertension
- Focus Therapeutic Use
- 09 Aug 2013 New trial record